J Liver Cancer Search


J Liver Cancer > Volume 15(1); 2015 > Article
Journal of Liver Cancer 2015;15(1):36-40.
DOI: https://doi.org/10.17998/jlc.15.1.36    Published online March 31, 2015.
Hemangioma Diagnosed by Gadoxetate Disodium-Enhanced MRI in a Patient with Chronic Hepatitis C
Jin Won Mo1, Soo Hyung Ryu1, Dong Won Park1, Won Jae Yoon1, Jin Nam Kim1, Jeong Seop Moon1, Jae-Chan Shim2
1Departments of 1Internal Medicine, Inje University Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea
2Departments of Radiology, Inje University Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea
Correspondence:  Soo Hyung Ryu,
Email: rshdrryu@medimail.co.kr
A hemangioma is the most common benign hepatic tumor. Many hepatic hemangioma tend to be found incidentally, but should be differentiated from malignant tumors, especially in patients with a high risk for malignancy. We presented a 52-year-old woman who diagnosed as hepatic hemangioma. The patient was a chronic alcohol abuser and diagnosed as a hepatic C virus carrier for the first time. Contrast enhanced abdominal computed tomography (CT) revealed a 4cm sized hepatic mass involving both segment 5 and 6. Abdominal CT finding suggested hepatic hemangioma, but could not rule out the malignancy. Because the patient had risk factors for hepatocellular carcinoma, abdominal ultrasonography (US) was performed for further evaluation. But abdominal US also showed atypical finding. For the confirmative diagnosis, dynamic magnetic resonance imaging using gadoxetate disodium (primovist®, Bayer HealthCare, Berlin, Germany) which is the innovative liver cell-specific contrast medium was done, and the patient was diagnosed as hepatic hemangioma.
Key Words: Hepatitis C; Hemangioma; Gadoxetate disodium; Magnetic resonance imaging
Share :
Facebook Twitter Linked In Google+ Line it
METRICS Graph View
  • 0 Crossref
  • 642 View
  • 9 Download
Related articles in J Liver Cancer

Editorial Office
620 Yeoksam Heights Bldg.(FASTFIVE),151 Teheran-ro, Gangnam-gu, Seoul 06132, Korea
Tel: +82-2-313-1900    E-mail: liver@klcsg.or.kr                

Copyright © 2022 by The Korean Liver Cancer Association.

Developed in M2PI

Close layer
prev next